Tie1 is required for lymphatic valve and collecting vessel development

Developmental Biology

Volumn 399, Issue 1, 2015, Pages 117-128

  Qu, Xianghu ^a   Zhou, Bin ^c   Scott Baldwin, H ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Conditional knockout; Lymphatic valve; Lymphatic vessel remodeling; Lymphovenous valve; Prox1; Tie1

Indexed keywords

TIE 1 RECEPTOR;

ALLELE; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE; LOXP SITE; LYMPH FLOW; LYMPH VESSEL; LYMPH VESSEL ENDOTHELIUM; LYMPHANGIOGENESIS; LYMPHATIC SYSTEM; LYMPHATIC VALVE; MORPHOGENESIS; MOUSE; NFATC1 GENE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TIE1 GENE; TURBULENT FLOW; ANIMAL; ANIMAL EMBRYO; C57BL MOUSE; EMBRYOLOGY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; METABOLISM; NEWBORN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

MUS;

ANIMALS; ANIMALS, NEWBORN; EMBRYO, MAMMALIAN; GENE EXPRESSION REGULATION, DEVELOPMENTAL; IMMUNOHISTOCHEMISTRY; LYMPHANGIOGENESIS; LYMPHATIC SYSTEM; LYMPHATIC VESSELS; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTOR, TIE-1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84924015308     PISSN: 00121606     EISSN: 1095564X     Source Type: Journal    
DOI: 10.1016/j.ydbio.2014.12.021     Document Type: Article

References (58)

1. Abtahian F., Guerriero A., Sebzda E., Lu M.M., Zhou R., Mocsai A., Myers E.E., Huang B., Jackson D.G., Ferrari V.A., et al. Regulation of blood and lymphatic vascular separation by signaling proteins SLP-76 and Syk. Science 2003, 299:247-251.
2. Alitalo K. The lymphatic vasculature in disease. Nat. Med. 2011, 17:1371-1380.
3. Augustin H.G., Koh G.Y., Thurston G., Alitalo K. Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat. Rev. Mol. Cell Biol. 2009, 10:165-177.
4. Bazigou E., Makinen T. Flow control in our vessels: vascular valves make sure there is no way back. Cell. Mol. Life Sci. 2013, 70:1055-1066.
5. Bazigou E., Lyons O.T., Smith A., Venn G.E., Cope C., Brown N.A., Makinen T. Genes regulating lymphangiogenesis control venous valve formation and maintenance in mice. J. Clin. Investig. 2011, 121:2984-2992.
6. Bazigou E., Xie S., Chen C., Weston A., Miura N., Sorokin L., Adams R., Muro A.F., Sheppard D., Makinen T. Integrin-alpha9 is required for fibronectin matrix assembly during lymphatic valve morphogenesis. Dev. Cell 2009, 17:175-186.
7. Bouvrée K., Brunet I., Del Toro R., Gordon E., Prahst C., Cristofaro B., Mathivet T., Xu Y., Soueid J., Fortuna V., et al. Semaphorin3A, Neuropilin-1, and PlexinA1 are required for lymphatic valve formation. Circ. Res. 2012, 111:437-445.
8. Chen-Konak L., Guetta-Shubin Y., Yahav H., Shay-Salit A., Zilberman M., Binah O., Resnick N. Transcriptional and post-translation regulation of the Tie1 receptor by fluid shear stress changes in vascular endothelial cells. FASEB J. 2003, 17:2121-2123.
9. Chlench S., Mecha Disassa N., Hohberg M., Hoffmann C., Pohlkamp T., Beyer G., Bongrazio M., Da Silva-Azevedo L., Baum O., Pries A.R., Zakrzewicz A. Regulation of Foxo-1 and the angiopoietin-2/Tie2 system by shear stress. FEBS Lett. 2007, 581:673-680.
10. D'Amico G., Korhonen E.A., Waltari M., Saharinen P., Laakkonen P., Alitalo K. Loss of endothelial Tie1 receptor impairs lymphatic vessel development-brief report. Arterioscler. Thromb. Vasc. Biol. 2010, 30:207-209.
11. Danussi C., Del Bel Belluz L., Pivetta E., Modica T.M., Muro A., Wassermann B., Doliana R., Sabatelli P., Colombatti A., Spessotto P. EMILIN1/α9β1 integrin interaction is crucial in lymphatic valve formation and maintenance. Mol. Cell. Biol. 2013, 33:4381-4394.
12. Dellinger M., Hunter R., Bernas M., Gale N., Yancopoulos G., Erickson R., Witte M. Defective remodeling and maturation of the lymphatic vasculature in Angiopoietin-2 deficient mice. Dev. Biol. 2008, 319:309-320.
13. Dumont D.J., Fong G.H., Puri M.C., Gradwohl G., Alitalo K., Breitman M.L. Vascularization of the mouse embryo: a study of flk-1, tek, tie, and vascular endothelial growth factor expression during development. Dev. Dyn. 1995, 203:80-92.
14. Fukuhara S., Sako K., Minami T., Noda K., Kim H.Z., Kodama T., Shibuya M., Takakura N., Koh G.Y., Mochizuki N. Differential function of Tie2 at cell-cell contacts and cell-substratum contacts regulated by angiopoietin-1. Nat. Cell Biol. 2008, 10:513-526.
15. Gale N.W., Thurston G., Hackett S.F., Renard R., Wang Q., McClain J., Martin C., Witte C., Witte M.H., Jackson D., et al. Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. Dev. Cell 2002, 3:411-423.
16. Gupta S., Ramjaun A.R., Haiko P., Wang Y., Warne P.H., Nicke B., Nye E., Stamp G., Alitalo K., Downward J. Binding of ras to phosphoinositide 3-kinase p110alpha is required for ras-driven tumorigenesis in mice. Cell 2007, 129:957-968.
17. Jurisic G., Maby-El Hajjami H., Karaman S., Ochsenbein A.M., Alitalo A., Siddiqui S.S., Ochoa Pereira C., Petrova T.V., Detmar M. An unexpected role of semaphorin3a-neuropilin-1 signaling in lymphatic vessel maturation and valve formation. Circ. Res. 2012, 111:426-436.
18. Kanady J.D., Dellinger M.T., Munger S.J., Witte M.H., Simon A.M. Connexin37 and Connexin43 deficiencies in mice disrupt lymphatic valve development and result in lymphatic disorders including lymphedema and chylothorax. Dev. Biol. 2011, 354:253-266.
19. Kazenwadel J., Secker G.A., Liu Y.J., Rosenfeld J.A., Wildin R.S., Cuellar-Rodriguez J., Hsu A.P., Dyack S., Fernandez C.V., Chong C.E., et al. Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature. Blood 2012, 119:1283-1291.
20. Koltowska K., Betterman K.L., Harvey N.L., Hogan B.M. Getting out and about: the emergence and morphogenesis of the vertebrate lymphatic vasculature. Development 2013, 140:1857-1870.
21. Kontos C.D., Cha E.H., York J.D., Peters K.G. The endothelial receptor tyrosine kinase Tie1 activates phosphatidylinositol 3-kinase and Akt to inhibit apoptosis. Mol. Cell Biol. 2002, 22:1704-1713.
22. Kulkarni R.M., Greenberg J.M., Akeson A.L. NFATc1 regulates lymphatic endothelial development. Mech. Dev. 2009, 126:350-365.
23. Lee H.J., Koh G.Y. Shear stress activates Tie2 receptor tyrosine kinase in human endothelial cells. Biochem. Biophys. Res. Commun. 2003, 304:399-404.
24. Levet S., Ciais D., Merdzhanova G., Mallet C., Zimmers T.A., Lee S.J., Navarro F.P., Texier I., Feige J.J., Bailly S., Vittet D. Bone morphogenetic protein 9 (BMP9) controls lymphatic vessel maturation and valve formation. Blood 2013, 122:598-607.
25. Li D.Y., Sorensen L.K., Brooke B.S., Urness L.D., Davis E.C., Taylor D.G., Boak B.B., Wendel D.P. Defective angiogenesis in mice lacking endoglin. Science 1999, 284:1534-1537.
26. Makinen T., Adams R.H., Bailey J., Lu Q., Ziemiecki A., Alitalo K., Klein R., Wilkinson G.A. PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature. Genes Dev. 2005, 19:397-410.
27. Mancini M.L., Verdi J.M., Conley B.A., Nicola T., Spicer D.B., Oxburgh L.H., Vary C.P. Endoglin is required for myogenic differentiation potential of neural crest stem cells. Dev. Biol. 2007, 308:520-533.
28. Marron M.B., Hughes D.P., Edge M.D., Forder C.L., Brindle N.P.-J. Evidence for heterotypic interaction between the receptor tyrosine kinases Tie-1 and Tie-2. J. Biol. Chem. 2000, 275:39741-39746.
29. Marron M.B., Singh H., Tahir T.A., Kavumkal J., Kim H.-Z., Koh G.Y., Brindle N.P. Regulated proteolytic processing of Tie1 modulates ligand responsiveness of the receptor tyrosine kinase Tie2. J. Biol. Chem. 2007, 282:30509-30517.
30. Mouta-Bellum C., Kirov A., Miceli-Libby L., Mancini M.L., Petrova T.V., Liaw L., Prudovsky I., Thorpe P.E., Miura N., Cantley L.C., et al. Organ-specific lymphangiectasia, arrested lymphatic sprouting, and maturation defects resulting from gene-targeting of the PI3 K regulatory isoforms p85alpha, p55alpha, and p50alpha. Dev. Dyn. 2009, 238:2670-2679.
31. Norrmén C., Ivanov K.I., Cheng J., Zangger N., Delorenzi M., Jaquet M., Miura N., Puolakkainen P., Horsley V., Hu J., et al. FOXC2 controls formation and maturation of lymphatic collecting vessels through cooperation with NFATc1. J. Cell Biol. 2009, 185:439-457.
32. Oliver G., Alitalo K. The lymphatic vasculature: recent progress and paradigms. Annu. Rev. Cell Biol. 2005, 21:457-483.
33. Oliver G., Detmar M. The rediscovery of the lymphatic system: old and new insights into the development and biological function of the lymphatic vasculature. Genes Dev. 2002, 16:773-783.
34. Oliver G., Srinivasan R.S. Lymphatic vasculature development: current concepts. Ann. N.Y. Acad. Sci. 2008, 1131:75-81.
35. Partanen J., Armstrong E., Makela T.P., Korhonen J., Sandberg M., Renkonen R., Knuutila S., Huebner K., Alitalo K. A novel endothelial cell surface receptor tyrosine kinase with extracellular epidermal growth factor homology domains. Mol. Cell. Biol. 1992, 12:1698-1707.
36. Peters K.G., Kontos C.D., Lin P.C., Wong A.L., Rao P., Huang L., Dewhirst M.W., Sankar S. Functional significance of Tie2 signaling in the adult vasculature. Recent Prog. Horm. Res. 2004, 59:51-71.
37. Porat R.M., Grunewald M., Globerman A., Itin A., Barshtein G., Alhonen L., Alitalo K., Keshet E. Specific induction of tie1 promoterby disturbed flow in atherosclerosis-prone vascularniches and flow-obstructing pathologies. Circ. Res. 2004, 94:394-401.
38. Puri M.C., Rossant J., Alitalo K., Bernstein A., Partanen J. The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells. EMBO J. 1995, 14:5884-5891.
39. Qu X., Tompkins K., Batts L.E., Puri M., Baldwin S. Abnormal embryonic lymphatic vessel development in Tie1 hypomorphic mice. Development 2010, 137:1285-1295.
40. Ranger A.M., Grusby M.J., Hodge M.R., Gravallese E.M., de la Brousse F.C., Hoey T., Mickanin C., Baldwin H.S., Glimcher L.H. The transcription factor NF-ATc is essential for cardiac valve formation. Nature 1998, 392:186-190.
41. Ringelmann B., Roder C., Hallmann R., Maley M., Davies M., Grounds M., Sorokin L. Expression of laminin alpha1, alpha2, alpha4, and alpha5 chains, fibronectin, and tenascin-C in skeletal muscle of dystrophic 129ReJ dy/dy mice. Exp. Cell Res. 1999, 246:165-182.
42. Sabine A., Agalarov Y., Maby-El Hajjami H., Jaquet M., Hägerling R., Pollmann C., Bebber D., Pfenniger A., Miura N., Dormond O., et al. Mechanotransduction, PROX1, and FOXC2 cooperate to control connexin37 and calcineurin during lymphatic-valve formation. Dev. Cell 2012, 22:430-445.
43. Saharinen P., Eklund L., Miettinen J., Wirkkala R., Anisimov A., Winderlich M., Nottebaum A., Vestweber D., Deutsch U., Koh G.Y., et al. Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts. Nat. Cell Biol. 2008, 10:527-537.
44. Sato T.N., Tozawa Y., Deutsch U., Wolburg-Buchholz K., Fujiwara Y., Gendron-Maguire M., Gridley T., Wolburg H., Risau W., Qin Y. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 1995, 376:70-74.
45. Schulte-Merker S., Sabine A., Petrova T.V. Lymphatic vascular morphogenesis in development, physiology, and disease. J. Cell Biol. 2011, 193:607-618.
46. Seegar T.C., Eller B., Tzvetkova-Robev D., Kolev M.V., Henderson S.C., Nikolov D.B., Barton W.A. Tie1-Tie2 interactions mediate functional differences between angiopoietin ligands. Mol. Cell 2010, 37:643-655.
47. Shen B., Shang Z., Wang B., Zhang L., Zhou F., Li T., Chu M., Jiang H., Wang Y., Qiao T., et al. Genetic dissection of tie pathway in mouse lymphatic maturation and valve development. Arterioscler. Thromb. Vasc. Biol. 2014, 34:1221-1230.
48. Song S.H., Kim K.L., Lee K.A., Suh W. Tie regulates the Tie2 agonistic role of angiopoietin-2 in human lymphatic endothelial cells. Bichem. Biophys. Res. Commun. 2012, 419:281-286.
49. Srinivasan R.S., Oliver G. Prox1 dosage controls the number of lymphatic endothelial cell progenitors and the formation of the lymphovenous valves. Genes Dev. 2011, 25:2187-2197.
50. Tammela T., Alitalo K. Lymphangiogenesis: molecular mechanisms and future promise. Cell 2010, 140:460-476.
51. Turner C.J., Badu-Nkansah K., Crowley D., van der Flier A., Hynes R.O. Integrin-α5β1 is not required for mural cell functions during development of blood vessels but is required for lymphatic-blood vessel separation and lymphovenous valve formation. Dev. Biol. 2014, 392:381-392.
52. Woo K.V., Baldwin H.S. Role of Tie1 in shear stress and atherosclerosis. Trends Cardiovasc. Med. 2011, 21:118-123.
53. Woo K.V., Qu X., Babaev V.R., Linton M.F., Guzman R.J., Fazio S., Baldwin H.S. Tie1 attenuation reduces murine atherosclerosis in a dose-dependent and shear stress-specific manner. J. Clin. Investig. 2011, 121:1624-1635.
54. Wu B., Zhang Z., Lui W., Chen X., Wang Y., Chamberlain A.A., Moreno-Rodriguez R.A., Markwald R.R., O'Rourke B.P., Sharp D.J., et al. Endocardial cells form the coronary arteries by angiogenesis through myocardial-endocardial VEGF signaling. Cell 2012, 151:1083-1096.
55. Yancopoulos G.D., Davis S., Gale N.W., Rudge J.S., Wiegand S.J., Holash J. Vascular-specific growth factors and blood vessel formation. Nature 2000, 407:242-248.
56. Yuan H.T., Venkatesha S., Chan B., Deutsch U., Mammoto T., Sukhatme V.P., Woolf A.S., Karumanchi S.A. Activation of the orphan endothelial receptor Tie1 modifies Tie2-mediated intracellular signaling and cell survival. FASEB J. 2007, 21:3171-3183.
57. Zheng W., Nurmi H., Appak S., Sabine A., Bovay E., Korhonen E.A., Orsenigo F., Lohela M., D'Amico G., Holopainen T., et al. Angiopoietin 2 regulates the transformation and integrity of lymphatic endothelial cell junctions. Genes Dev. 2014, 28:1592-1603.
58. Zhou F., Chang Z., Zhang L., Hong Y.K., Shen B., Wang B., Zhang F., Lu G., Tvorogov D., Alitalo K., et al. Akt/protein kinase B is required for lymphatic network formation, remodeling, and valve development. Am. J. Pathol. 2010, 177:2124-2133.